Xerostomia Therapeutics Market Size Worth USD 3.32 Billion by 2034 | CAGR 4.1%

The xerostomia therapeutics market size is expected to reach USD 3.32 billion by 2034, according to a new study by Polaris Market Research. The report “Xerostomia Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (OTC and Prescription), By Product, By Distribution Channel, By Product Form, By Application, By End User, and By Region – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The xerostomia therapeutics market focuses on products designed to manage dry mouth. Dry mouth is a condition where the salivary glands do not produce enough saliva. This condition can cause discomfort and potentially lead to oral health problems. The market includes salivary stimulants, substitutes, and oral care products. The medication is aimed at relieving symptoms and improving oral health. The market growth is driven by factors such as an elderly population and increasing awareness about xerostomia. Also, the rising commonness of conditions such as Sjögren's syndrome and side effects from medications are fueling the market growth.

Xerostomia therapeutics market opportunities lie in the development of more effective and personalized treatments. These opportunities are due to advancements in salivary stimulants and substitutes. Trends include the growing demand for over-the-counter (OTC) solutions, innovations in oral healthcare products, and the expanding use of digital marketing strategies. Overall, the market demand is expected to grow steadily during the forecast period. The growth is fueled by the increasing number of affected individuals, the development of advanced treatment options, and expanding awareness globally.

Xerostomia Therapeutics Market Report Highlights

• North America recorded the largest regional share of 42.0% in 2025. High commonness of dry mouth-related conditions, strong awareness initiatives, and well-developed healthcare systems support the regional market growth.
• The Asia Pacific region is expected to witness 5.46% CAGR during the forecast period. Increasing research activities, broadening heathcare infrastructure, and rising prevalence of chronic diseases are driving regional market growth.
• The OTC segment accounted for a significant share of the xerostomia therapeutics market in 2025, accounting for 57.5% share. OTC products are generaly preferred due to their easy availability and symptomatic relief from dry mouth. Patients usually require sprays, gels, lozenges, and rinses for symptomatic treatment.
• The salivary stimulants segment held a major share of the market capturing 41.5% share in 2025. These products help activate residual salivary gland function. They provide ease for patients experiencing dry mouth condition.

   

Where is the Market Headed?

The xerostomia therapeutics market is shifting toward more accessible and patient-friendly dry mouth treatments. These remedies include OTC sprays, gels, rinses, and saliva substitutes. They provide quick symptom relief. Companies are focusing on improving product effectiveness and developing longer-lasting oral care solutions. To expand market reach, vendors are strengthening distribution through pharmacies, e-commerce platforms, and healthcare partnerships. Xerostomia therapeutics are becoming important for improving oral health and managing dry mouth conditions in the aging population.

What does Xerostomia Therapeutics Market Report Reveals?

• What is the global market size and CAGR for the market during 2026–2034?

• Who are the key industry players? What is their relative position in terms of competitive positioning?

• What factors are contributing largely to the industry expansion?

• How do different distribution channels, such as retail pharmacies, hospital pharmacies, and online pharmacies, influence the market landscape?

• How does the market differ in terms of type, product, distribution channel, product form, application, end user, and geography? Which is the leading product form?

• What are the opportunities in different regional markets, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?

• What are the emerging technologies and innovations in the market?

Request a free sample copy or read the full market insights : Xerostomia Therapeutics Market Report

Polaris Market Research has segmented the market report on the basis of type, product, distribution channel, product form, application, end user, and region:

By Type Outlook (Revenue – USD Billion, 2021–2034)

• OTC

• Prescription

By Product Outlook (Revenue – USD Billion, 2021–2034)

• Saivary Stimulants

• Saivary Substitutes

• Dentifrices

By Distribution Channel Outlook (Revenue – USD Billion, 2021–2034)

• Retai Pharmacies

• Onine Pharmacies/E-Commerce

• Hospita/Clinic Dispensing

By Product Form Outlook (Revenue – USD Billion, 2021–2034)

• Sprays

• Ges

• Rinses/Mouthwashes

• Lozenges

By End User Outlook (Revenue – USD Billion, 2021–2034)

• Denta Clinics

• Hospitas and Oncology Centers

• Homecare Settings

By Application Outlook (Revenue – USD Billion, 2021–2034)

• Radiation-Induced Xerostomia (RIX)

• Sjögren’s Syndrome-Reated Xerostomia

• Medication-Induced Xerostomia

By Regional Outlook (Revenue – USD Billion, 2021–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa